Difference between revisions of "Team:NTU-LIHPAO-Taiwan/Modeling/Conclusion"
Line 665: | Line 665: | ||
list-style-type: decimal; | list-style-type: decimal; | ||
margin-left: 0px; | margin-left: 0px; | ||
− | |||
− | |||
} | } | ||
Line 825: | Line 823: | ||
<li><a href="#First2">Conclusion</a></li> | <li><a href="#First2">Conclusion</a></li> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
</ul> | </ul> | ||
</li> | </li> | ||
Line 867: | Line 859: | ||
<div class="Text1">Modeling Summary</div> | <div class="Text1">Modeling Summary</div> | ||
<div class="Text2" id="First1">Hypothesis</div> | <div class="Text2" id="First1">Hypothesis</div> | ||
− | |||
− | |||
− | |||
<div class="Text3"> | <div class="Text3"> | ||
<ol class="part2"> | <ol class="part2"> | ||
Line 913: | Line 902: | ||
This general formula is based on one-dose response, and continuous drug intake should be further modified by successive accumulation for determining the appetite suppression effect. | This general formula is based on one-dose response, and continuous drug intake should be further modified by successive accumulation for determining the appetite suppression effect. | ||
</div> | </div> | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
Revision as of 14:20, 14 September 2015
- Modeling Summary
Modeling Summary
Hypothesis
- Total oral ingestion of 109 L. casei on the first day.
- The varying ratio (%) of bacteria number to total ingested number attached on the intestine against time were according to the mouse experiment.
- Incorporate suicide mechanism: 4 days for bacteria survival.
- TAT penetrates through villi by an uncharacterized pinocytosis/endocytosis related mechanism, which is also receptor-independent.
- CPP-PYY complex production rate per L. casei : 10-10 μg/min.
- One-fourth of the products secreted from L. casei penetrate through the small intestine epithelial cells, without being digested by the intestine fluid.
- Effective permeability of TAT-insulin conjugates from literature as reference for TAT-PYY complex : Peff = 1.62×10-5 (cm/s).
- Mean total mucosal surface of the small intestine interior averages 32 m2.
- L. casei cell size range = 0.7-1.1 x 2.0-4.0 μm. One-tenth of the bacteria height multiplied the mucosa surface area for the donor chamber volume.
- Fick’s Law of Binary Diffusion applied for CPP-PYY complex adsorption into bloodstream. Interstitial fluid diffusion coefficient of bovine serum albumin in tissues was taken for reference : DAB = 5.8 x 10-7 cm2/s.
- The distance from epithelial cells to capillaries is 4 μm.
- The diffusion is rapid enough to adsorb all the products in every minute.
- All the calculation was based on reaching steady-state condition in the interval of every minute discretely.
- Thrombin cleavage efficiency of Arg-Ser(R-S) site in CPP-PYY complex was referred to Arg-Thr(R-T) site in salmon calcitonin.
- Nearly 100 % of the complexes would be cleaved during 30 minutes due to the fluid motion in circulation.
- PYY concentration of 100 pg/ml has the power of appetite suppression without drug resistance.
- Average total blood volume of 5 liter in human body.
Conclusion
Ideally, the optimal concentration of PYY is 0.1 μg/L for appetite suppression, giving little side effect. Here we performed the simulation with 109 of total L. casei intake, and 10-10 μg/min of CPP-PYY complex production rate per L. casei. The results is shown below.
[Fig.1-1] Final concentration of PYY (μg/L) in the blood vessel
By building the model for simulation step by step, we summarized the general formula with varies parameters to determine the dose response :
[Final concentration of PYY in the blood (μg/L)] = 11745 × [Total L. casei intake] × [Distribution ratio of L. casei] × [CPP-PYY complex production rate per L. casei (μg/min)]
This general formula is based on one-dose response, and continuous drug intake should be further modified by successive accumulation for determining the appetite suppression effect.
Maintained by the iGEM team NTU-LIHPAO-Taiwan ©2015 NTU-LIHPAO-Taiwan